
Northwestern Medicine scientists have uncovered a surprising link between a tiny cellular engine and the way cancer cells build the DNA they need to proliferate, according to a new study published in Molecular Cell.

A team of Northwestern investigators has discovered novel molecular underpinnings of a common oncogenic mutation in cancer, findings that may inform the development of new therapeutic strategies, according to findings published in Nature Chemical Biology.

Distinguished biochemist Svetlana Mojsov, PhD, the Lulu Chow Wang and Robin Chemers Neustein Research Associate Professor at the Rockefeller University, New York, has been named the winner of the annual $250,000 Kimberly Prize in Biochemistry and Molecular Genetics.

A new study has shed light on how a class of diabetes drugs may protect the kidneys — not just by lowering blood sugar, but by triggering a molecular shift that dampens inflammation, according to the study published in The Journal of Clinical Investigation.

Northwestern Medicine scientists have developed a comprehensive atlas of genetic coding sequences in both healthy adult hearts and those with heart failure, as detailed in a recent study published in Circulation.

Northwestern Medicine scientists have discovered that a subset of laboratory-modified T-cells can promote the repair of lung tissue damaged by viral pneumonia, according to a recent study published in The Journal of Clinical Investigation.

Northwestern scientists have discovered that the organization of a cell’s genetic material dictates cancer’s ability to adapt, according to a recent study published in the Proceedings of the National Academy of Sciences.

Investigators led by Navdeep Chandel, PhD, have discovered how mitochondrial metabolism supports T-cell proliferation and also prevents T-cell exhaustion in cancer and chronic infection, according to a recent study published in Nature Immunology.

Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and respond to disease and acute inflammation, findings that may inform the development of targeted therapies for cancer and tissue injury, according to a recent study published in the Journal of Clinical Investigation.

Esteemed molecular biologist Ron Evans, PhD, known for his groundbreaking discovery of the nuclear receptor superfamily, delivered the third Kimberly Prize in Biochemistry and Molecular Genetics Lecture to a crowded auditorium of Feinberg faculty, staff, fellows and students on April 30.